Global Allergy Treatment Market 2021-2027

February 2022 | 81 pages | ID: GF65BBC26846EN
Gen Consulting Company

Abstracts

Allergies are a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. Allergies can cause a variety of symptoms such as a runny nose, sneezing, itching, rashes, swelling, or asthma. Garnering a CAGR of 6.2% from 2021 to 2027, the global allergy treatment market is projected to reach worth of USD 36,675 million by 2027-end, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global allergy treatment market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the allergy treatment industry.

The allergy treatment market is segmented on the basis of treatment, dosage form, indication, distribution channel, and distribution channel. The allergy treatment market is segmented as below:

By treatment:

• anti-allergy drugs
• immunotherapy

By dosage form:

• oral
• nasal
• others

By indication:

• eye allergy
• skin allergy
• food allergy
• rhinitis
• asthma
• others

By distribution channel:

• distribution channel
• hospitals pharmacies
• retail pharmacies
• online sales
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides a detailed analysis of several leading allergy treatment market vendors that include AbbVie Inc. (Allergan plc), ALK-Abello A/S, Allergy Therapeutics PLC, Boehringer Ingelheim International GmbH, Dermapharm Holding SE, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, LETI Pharma, S.L.U., Sanofi S.A., Stallergenes Greer Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global allergy treatment market.
• To classify and forecast the global allergy treatment market based on treatment, dosage form, indication, distribution channel, and distribution channel.
• To identify drivers and challenges for the global allergy treatment market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global allergy treatment market.
• To identify and analyze the profile of leading players operating in the global allergy treatment market.

Why Choose This Report

• Gain a reliable outlook of the global allergy treatment market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR ALLERGY TREATMENT BY TREATMENT

5.1 Anti-allergy drugs
  5.1.1 Market size and forecast
5.2 Immunotherapy
  5.2.1 Market size and forecast

PART 6. GLOBAL MARKET FOR ALLERGY TREATMENT BY DOSAGE FORM

6.1 Oral
  6.1.1 Market size and forecast
6.2 Nasal
  6.2.1 Market size and forecast
6.3 Others
  6.3.1 Market size and forecast

PART 7. GLOBAL MARKET FOR ALLERGY TREATMENT BY INDICATION

7.1 Eye allergy
  7.1.1 Market size and forecast
7.2 Skin allergy
  7.2.1 Market size and forecast
7.3 Food allergy
  7.3.1 Market size and forecast
7.4 Rhinitis
  7.4.1 Market size and forecast
7.5 Asthma
  7.5.1 Market size and forecast
7.6 Others
  7.6.1 Market size and forecast

PART 8. GLOBAL MARKET FOR ALLERGY TREATMENT BY DISTRIBUTION CHANNEL

8.1 Hospitals pharmacies
  8.1.1 Market size and forecast
8.2 Retail pharmacies
  8.2.1 Market size and forecast
8.3 Online sales
  8.3.1 Market size and forecast
8.4 Others
  8.4.1 Market size and forecast

PART 9. GLOBAL MARKET FOR ALLERGY TREATMENT BY REGION

9.1 Asia Pacific
  9.1.1 Market size and forecast
9.2 Europe
  9.2.1 Market size and forecast
9.3 North America
  9.3.1 Market size and forecast
9.4 Rest of the World (RoW)
  9.4.1 Market size and forecast

PART 10. KEY COMPETITOR PROFILES

10.1 AbbVie Inc. (Allergan plc)
10.2 ALK-Abello A/S
10.3 Allergy Therapeutics PLC
10.4 Boehringer Ingelheim International GmbH
10.5 Dermapharm Holding SE
10.6 F. Hoffmann-La Roche Ltd.
10.7 GlaxoSmithKline plc
10.8 Johnson & Johnson
10.9 LETI Pharma, S.L.U.
10.10 Sanofi S.A.
10.11 Stallergenes Greer Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY